J Korean Soc Transplant.  1999 Jun;13(1):141-148.

An Incidence of Childhood Epstein-Barr Virus Infection and Lymphoproliferative Disease after Liver Transplantation

Affiliations
  • 1Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • 2Department of Clinical Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • 3Department of Diagnostic Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • 4Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Abstract

Epstein-Barr virus (EBV)-associated disease is known to be one of the major complication after transplantation. Early identification and diagnosis is crucial. The objectives of this study are to evaluate the incidence and to analyze the risk factors of EBV-associated disease. Twenty-five children with liver transplantation from Oct. 1994 to Oct. 1997 had been surveyed. Laboratory data of EBV infection such as anti-viral capsid antigen (VCA) IgM and IgG, EBV PCR, EBV encoded small RNA (EBER) in situ hybridization had been obtained at pre op, and post op 1, 2, 3, 4, 12, 24 weeks, then annually or when EBV infection was suspected. We classified these cases as asymptomatic infection, EBV syndrome, posttransplant lymphoproliferative disease (PTLD). And we analyzed the incidence of EBV infection according to age, type of immunosuppression, and CMV disease. Incidence of EBV infection in this study was 48% (12 out of 25), among them, 5 children were symptomatic and PTLD developed in 2 children. The significant risk factors were age at transplantation and CMV infection. One of PTLD cases resulting from EBV infection showed fatal outcome, the other was improved. We suggested that physicians especially in the care of the children after the liver transplantation should recognize the risk factors of the development of the EBV infection to avoid the progression into the potentially fatal PTLD.

Keyword

Epstein-Barr Virus infection; Posttransplant lymphoproliferative disease; Liver transplantation; Child

MeSH Terms

Asymptomatic Infections
Capsid
Child
Diagnosis
Epstein-Barr Virus Infections
Fatal Outcome
Herpesvirus 4, Human*
Humans
Immunoglobulin G
Immunoglobulin M
Immunosuppression
In Situ Hybridization
Incidence*
Liver Transplantation*
Liver*
Polymerase Chain Reaction
Risk Factors
RNA
Immunoglobulin G
Immunoglobulin M
RNA
Full Text Links
  • JKSTN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr